Chiroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chiroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: who wrote ()	12/9/1996 3:35:00 PM
From: James Reynolds	of 69

Helmut, Chiroscience is the company that is acquiring Darwin. Chiroscience is traded in London and its current share price is around œ3.30, which gives it a market cap of about œ260 million ($400 million). Chiroscience is a world leader in chiral technology and has numerous drugs in various stages of development. Levobupivacaine, its long acting anaesthetic is currently in Phase III trials and could be on the market by late 1998 or early 1999. Analysts are predicting annual sales for this drug alone in excess of œ150 million ($250 million). Other drugs with huge potential include MMP inhibitors for arthritis and cancer and PDE IV inhibitor for asthma.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next